ACR Releases Summary of MedPAC March Report
Highlighting MedPAC’s March findings on Medicare spending, payment adequacy, and key recommendations for physicians and hospitals.
Read moreMain Content
In April 2024, the U.S. Preventive Services Task Force changed the recommendations for imaging of non–BRCA-related breast cancer. The recommendations now state that biennial screening mammography is recommended for women ages 40 to 74, a pattern formerly suggested for women at least 50 years old.
The ACR® continues to recommend that all women have a breast cancer risk assessment by age 25. A screening benefit versus risk discussion is typically part of this assessment. The ACR also states that women at average risk for breast cancer should receive annual mammography screening starting at age 40.
A single screening mammogram poses the same risk as about 26 days of natural background radiation. This value is in comparison to a standard chest X-ray, which poses the same risk as roughly 10 days of background radiation exposure. Yet, mammograms use less radiation than an abdomen and pelvis CT, which is equivalent to 2.6 years of background radiation — or 5.1 years if repeated with and without contrast.
Despite these risks, imaging provides many benefits. Preventative screening and early detection are largely beneficial to patients in many ways, both physically and psychologically. For one, with earlier detection, patients can be treated earlier and thus benefit by increasing their chances of survival. Breast screening can also have a positive impact on women psychologically, which affects their overall well-being.
As healthcare professionals, we each carry the responsibility to advocate for our patients by encouraging preventative health screenings while helping mitigate the costs and dangers of unnecessary radiation. We should also work with our patients and consider their individual risk levels and family history. Lastly, as we continue following official guidelines and recommendations through the evolving literature, we can embrace our shared goal of helping patients, and as physicians, do no harm.
ACR Releases Summary of MedPAC March Report
Highlighting MedPAC’s March findings on Medicare spending, payment adequacy, and key recommendations for physicians and hospitals.
Read moreState AI Healthcare Bills Draw ACR Attention
State legislatures are advancing AI healthcare bills targeting insurer denials, clinical guardrails, and transparency for AI use in care and coverage.
Read moreACR Backs Fix to Burdensome Noridian TPE Reviews
ACR urges Noridian to end prepayment reviews of radiologists’ professional components, citing access barriers and high denial rates.
Read more